In the clinical MVA model, 2D-GLS and cTnT were independent predictors of survival in AL amyloidosis and 2D-GLS provided incremental value to the combination of NT-proBNP, cTnT, and other clinical parameters. Here, NPPB is linked to AL amyloidosis.